Mediwelcome Healthcare Management & Technology Inc. (2159.HK) Stock

About Mediwelcome Healthcare Management & Technology Inc.

Mediwelcome Healthcare Management & Technology Inc., an investment holding company, provides integrated healthcare marketing solutions in the People's Republic of China. The company offers academic conference management system, a digital management system for medical conference; scientific data reporting system, a technical service of single disease clinical research data collection; Medical Media, an official WeChat of tiantan international cerebrovascular disease conference; and health education media, a health science cloud platform, patient care center, patient management center, and health education media. It also provides medical conference, patient education and screening, and marketing strategy and consulting services; digital marketing and sales solutions services; contract research organization services; and internet hospital services. In addition, the company offers digital therapy services; science research and development services; and IT and software services. The company was founded in 2000 and is headquartered in Beijing, the People's Republic of China.

Mediwelcome Healthcare Management & Technology Inc. is led by CEO Liang Wang, employs 150 people, headquartered in Beijing, CN, publicly traded since 2021.

Mediwelcome Healthcare Management & Technology Inc. (2159.HK) stock trades at $1.68 with a market capitalization of $456.02M. The stock is valued at a price-to-earnings (P/E) ratio of 9.33, price-to-book of 3.11, price-to-sales of 0.80. Over the past 52 weeks the stock has ranged between $1.06 and $2.27, and currently trades 26.0% below its 52-week high.

On profitability, Mediwelcome Healthcare Management & Technology Inc. generates a return on equity (ROE) of 23.25% — well above the market average, a sign of a high-quality business, an operating margin of 8.54%, a net profit margin of 5.95%.

Official website: www.mediwelcome.com